External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<ul><li>WuXi XDC reported 2025 financial results, delivering a robust 46.7% YoY increase in revenue with a significant YoY growth of 69.9% for adj. attributable net profit.</li><li>The Company's 2025 revenue slightly beat our forecast by 0.6%, whereas its adj. net profit came in marginally below our estimate by 1.6%.</li><li>As of the end of 2025, its backlog surged by 50.3% YoY to reach US$1.49bn, while newly signed orders during the year grew by 41% YoY to US$1.33bn, sustaining the rapid growth momentum. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC reported 2025 financial results, delivering a robust 46.7% YoY increase in revenue with a significant YoY growth of 69.9% for adj. attributable net profit.The Company's 2025 revenue slightly beat our forecast by 0.6%, whereas its adj. net profit came in marginally below our estimate by 1.6%.As of the end of 2025, its backlog surged by 50.3% YoY to reach US$1.49bn, while newly signed orders during the year grew by 41% YoY to US$1.33bn, sustaining the rapid growth momentum. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC (2268 HK) - Ambitious Capacity Expansion to Continue

<ul><li>WuXi XDC issued a positive profit alert on its 2025 financial performance, expecting revenue to increase by at least 45% YoY and net profit to grow by more than 38% YoY.</li><li>Notably, the Company expected adjusted net profit before interest income and expenses to rise by more than 45% YoY and by over 65% YoY in 2025 if excluding the impact of foreign exchange fluctuations.</li><li>In 2025, WuXi XDC signed a record-high 70 new integrated projects, up by 32% YoY. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC issued a positive profit alert on its 2025 financial performance, expecting revenue to increase by at least 45% YoY and net profit to grow by more than 38% YoY.Notably, the Company expected adjusted net profit before interest income and expenses to rise by more than 45% YoY and by over 65% YoY in 2025 if excluding the impact of foreign exchange fluctuations.In 2025, WuXi XDC signed a record-high 70 new integrated projects, up by 32% YoY. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC (2268 HK) - Strong Earnings Growth with Strategic Acquisition to Enhance Capacity

<ul><li>WuXi XDC has evolved into a leader in the global XDC outsourcing service industry.</li><li>The Company provides “all-in-one” services in its facilities located in WuXi City, and is currently building manufacturing facilities in Singapore.</li><li>The Company is actively expanding its project pipeline, with 19 projects in PhIII and 11 in the PPQ stage. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC has evolved into a leader in the global XDC outsourcing service industry.The Company provides “all-in-one” services in its facilities located in WuXi City, and is currently building manufacturing facilities in Singapore.The Company is actively expanding its project pipeline, with 19 projects in PhIII and 11 in the PPQ stage. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

WuXi XDC (2268 HK) - A Rapidly-Growing Leader in Global XDC Field

China

WuXi XDC is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in antibody-drug conjugates (ADCs) and other bioconjugates. The company offers integrated, end-to-end services for the discovery, process development, and GMP manufacturing of bioconjugates, monoclonal antibody intermediates, and payload-linkers. WuXi XDC was founded in 2013 and is headquartered in Wuxi, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

WuXi XDC (2268 HK)

WuXi XDC (2268 HK) - Ambitious Capacity Expansion to Continue

WuXi XDC reported 2025 financial results, delivering a robust 46.7% YoY increase in revenue with a significant YoY growth of 69.9% for adj....

CMB International

WuXi XDC (2268 HK) - Strong Earnings Growth with Strategic Acquisition to Enhance Capacity

WuXi XDC issued a positive profit alert on its 2025 financial performance, expecting revenue to increase by at least 45% YoY and net profit to grow...

CMB International

WuXi XDC (2268 HK) - A Rapidly-Growing Leader in Global XDC Field

The Company provides “all-in-one” services in its facilities located in WuXi City, and is currently building manufacturing facilities in Singapore.

CMB International

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)